Illumina Buys VC-Backed Helixis
Illumina Inc. (Nasdaq: ILMN) has acquired Helixis Inc., a Carlsbad, Calif.-based developer of nucleic acid analysis tools. The deal is valued at up to $105 million, including a $70 million up-front payment. Helixis had raised over $15 million in VC funding from Advanced Technology Ventures, Domain Associates and Okapi Venture Capital.
28 July 2010•4 mins read
